Kawasaki Disease Refractory to Initial Therapy With Intravenous Immunoglobulin
1 clinical trials · Condition
◉ Watch Kawasaki Disease Refractory to Initial Therapy With Intravenous Immunoglobulin
| Record | Firm | Date |
|---|---|---|
| Clinical Study of TA-650 in Patients With Refractory Kawasaki Disease (NCT01596335) | Tanabe Pharma Corporation | 2012-05-01 |
Track Kawasaki Disease Refractory to Initial Therapy With Intravenous Immunoglobulin automatically
Every clearance here is in the API, with alerts when new ones post.